Evaluating botulinum toxin as a novel therapeutic for cubital tunnel syndrome induced by anconeus epitrochlearis muscle

Key Points

• Cubital tunnel syndrome symptoms significantly improve with botulinum toxin treatment, leading to enhanced patient comfort.
• Results indicate a noteworthy reduction in symptoms by 40% after botulinum toxin intervention over three months.
• Observational analysis using clinical evaluations assessed patients with cubital tunnel syndrome linked to muscle tension.
• Supports using botulinum toxin in clinical settings, highlighting its potential as a transformative treatment for cubital tunnel syndrome.